Design and manufacture of functional catalyst-carrier structures for the bioorthogonal activation of anticancer agents - New Journal of Chemistry (RSC Publishing)
![PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices](https://i1.rgstatic.net/publication/327472587_Bioorthogonal_Uncaging_of_the_Active_Metabolite_of_Irinotecan_by_Palladium-Functionalized_Microdevices/links/5c0abb0c299bf139c746e5a3/largepreview.png)
PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices
![PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices](https://www.researchgate.net/publication/327472587/figure/fig1/AS:701269647818753@1544207121307/a-Camptothecin-and-clinically-approved-derivatives-topotecan-and-irinotecan-b_Q320.jpg)
PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices
![Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-03617-x/MediaObjects/41467_2018_3617_Fig4_HTML.jpg)
Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications
![Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-018-03617-x/MediaObjects/41467_2018_3617_Fig1_HTML.jpg)
Designed heterogeneous palladium catalysts for reversible light-controlled bioorthogonal catalysis in living cells | Nature Communications
![Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis | Semantic Scholar Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/20bf469e638d1757da956778215f75424d8777c0/4-Figure2-1.png)
Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis | Semantic Scholar
![Palladium: a future key player in the nanomedical field? - Chemical Science (RSC Publishing) DOI:10.1039/C5SC00070J Palladium: a future key player in the nanomedical field? - Chemical Science (RSC Publishing) DOI:10.1039/C5SC00070J](https://pubs.rsc.org/image/article/2015/SC/c5sc00070j/c5sc00070j-f1_hi-res.gif)
Palladium: a future key player in the nanomedical field? - Chemical Science (RSC Publishing) DOI:10.1039/C5SC00070J
![Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis - Nat. Catal. - X-MOL Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis - Nat. Catal. - X-MOL](https://xpic.x-mol.com/20190910%2F10.1038_s41929-019-0333-4.jpg)
Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis - Nat. Catal. - X-MOL
![A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging† - Chem. Sci. - X-MOL A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging† - Chem. Sci. - X-MOL](https://xpic.x-mol.com/20180503%2F10.1039_C8SC00256H.jpg)
A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging† - Chem. Sci. - X-MOL
![PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices](https://www.researchgate.net/publication/327472587/figure/fig2/AS:701269647822855@1544207121358/a-Palladium-catalyzed-conversion-of-2c-into-1b-cRate-of-transformation-of-2c-100_Q320.jpg)
PDF) Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices
![Periodic Reporting for period 1 - ChemoBOOM (Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy) | Report Summary | ChemoBOOM | H2020 | CORDIS | European Commission Periodic Reporting for period 1 - ChemoBOOM (Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy) | Report Summary | ChemoBOOM | H2020 | CORDIS | European Commission](https://cordis.europa.eu/docs/results/h2020/658/658833_PS/image-for-summary-publication.jpg)
Periodic Reporting for period 1 - ChemoBOOM (Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy) | Report Summary | ChemoBOOM | H2020 | CORDIS | European Commission
![Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices. - Abstract - Europe PMC Bioorthogonal Uncaging of the Active Metabolite of Irinotecan by Palladium-Functionalized Microdevices. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6282958/bin/CHEM-24-16783-g001.jpg)